Narrative review guideline distinguishes episodic ataxia types using clinical features in limited resource settings.
Clinicians can distinguish two rare ataxia types using specific symptoms and triggers.
This narrative review guideline addresses episodic ataxia types 1 and 2 in limited resource settings where genetic testing is unavailable. I…
A review suggests doctors in areas with limited testing can tell apart two rare ataxia conditions by looking at attack duration and unique s…
Retrospective analysis of 41,775 reports identifies signals for cognitive disorders with 50 medications including finasteride and diltiazem.
Analysis of 50 drugs shows statistical links to cognitive issues in vulnerable groups
This retrospective disproportionality analysis examined 41,775 reports from the FDA, JADER, and WHO VigiAccess databases (2004–2024) involvi…
74% of 50 drugs linked to cognitive issues in reports lack FDA warnings, with signals stronger in vulnerable groups like children and senior…